TABLE 7.
Potential impact of the BioFire PN panel result on antibiotic utilization
| Potential modification | No. of antimicrobials | No. (%) of patients | No. of hrs |
|---|---|---|---|
| Appropriate de-escalation/discontinuation | 206 | 122 (48.2) | 18,284.07 |
| Appropriate escalation/initiation | 11 | 11 (4.3) | 184.66 |
| Inappropriate de-escalation/discontinuation | 4 | 4 (1.6) | |
| Inappropriate escalation/continuation | 42 | 42 (16.6) | |
| No change | 74 (29.2) | ||
| Unable to assessa | 16 |
a
No stop date was listed for antimicrobials, concomitant infection was present, or antimicrobials were used for longer durations than would be used for a lower respiratory tract infection (>30 days).